Serial #97819947
LIVE

Serial Number

97819947

Owner

Chan Zuckerberg Initiative, LLC

Attorney

Anthony Malutta

First Use Date

Mar 2, 2024

Filing Date

Mar 2, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #97819947 Trademark

Serial Number: 97819947 • Registration: 8254184

Serial #97819947 is a trademark filed by Chan Zuckerberg Initiative, LLC on March 2, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Chan Zuckerberg Initiative, LLC

Redwood City, CA 94063

Entity Type: 16

Trademark Details

Filing Date

March 2, 2023

Registration Date

May 12, 2026

First Use Anywhere

March 2, 2024

First Use in Commerce

March 2, 2024

Published for Opposition

February 6, 2024

Goods & Services

Arranging and conducting seminars, workshops, colloquia, lectures, non-downloadable webinars, multimedia presentations and training in the field of biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, biomedical imaging and imaging technology; Educational services, namely, providing educational conferences, symposiums and round-table discussions in the field of biomedical imaging and imaging technology; Providing online databases for educational use purposes in the field of biomedical imaging and imaging technology; Non-downloadable electronic publications, namely, letters, newsletters, articles, news stories, blogs and fact sheets in the field of biomedical imaging and imaging technology; providing a website featuring blogs in the fields of biomedical research, biotechnology, bioinformatics, bioengineering, data analytics and data science

Promoting technical and scientific investigation, research, and experimentation in the field of biomedical imaging and imaging technology; Promoting the exchange of information and resources within the scientific and medical research community and the technology industry to achieve advances in the field of biomedical imaging and imaging technology; Promoting public awareness of the biomedical imaging research field; Administration and management of research grants

Financial services, namely, providing grants and funding in the field of biomedical imaging and imaging technology research; Funds investment, namely, fund investment services in imaging technology products; Funds investment, namely, fund investment services in imaging technology development projects; Providing funding, namely, providing grants in the fields of scientific medical and biomedical research

Research, development and design of biomedical technologies and products; Development and design of computer software; Scientific research; Scientific research in the field of medicine; Medical research; Biomedical research; Biotechnology research; Technology services, namely, technological research and development in the field of biomedical imaging and imaging technology; Providing information about scientific, medical, biomedical and biotechnology research; Providing information about imaging technology; Providing facilities for scientific, medical, biomedical and biotechnology research; Providing a website featuring information in the field of biomedical imaging and imaging technology; research and development of vaccines and medicines; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; biotechnology research services, and research and development of new products in the field of gene therapeutics; design of genetic research tools and systems for others; compiling data for research purposes in the field of medical science; scientific research and development, namely, development of new scientific computational technologies to predict positive and negative regulators of gene network function; developing new technology for others in the field of computational genomics; genome sequencing services for scientific and research purposes; providing genetic sequencing and consulting services for clinical research purposes; Genetic testing for medical research purposes; medical diagnostic testing, monitoring and reporting services for research purposes; providing genetic sequencing and consulting services for medical research purposes

Downloadable software for biomedical imaging; Imaging technology, namely, downloadable open-source software for visualizing and analyzing multi-channel imaging datasets

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 12, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 12, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 21, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 21, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 1, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 31, 2026 AITU
USE AMENDMENT FILED
Oct 1, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 1, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
Apr 3, 2025 EX2G
SOU EXTENSION 2 FILED
Apr 2, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 2, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 30, 2024 EXRA
SOU EXTENSION 1 GRANTED
Sep 30, 2024 EX1G
SOU EXTENSION 1 FILED
Sep 30, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 30, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 2, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 6, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 29, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 29, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 29, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 29, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 29, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 7, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 3, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 3, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 3, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 30, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 23, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 22, 2023 NWOS
NEW APPLICATION ENTERED
Mar 6, 2023 NWAP